DOCK9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.002600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.312000E-02
Normal-vs-Stage2
2.692000E-01
Normal-vs-Stage3
5.147800E-01
Normal-vs-Stage4
1.569560E-01
Stage1-vs-Stage2
7.809200E-01
Stage1-vs-Stage3
5.621100E-03
Stage1-vs-Stage4
2.953400E-01
Stage2-vs-Stage3
8.658100E-02
Stage2-vs-Stage4
6.985200E-01
Stage3-vs-Stage4
5.565900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.065000E-01
Normal-vs-AfricanAmerican
2.312400E-01
Normal-vs-Asian
6.635800E-01
Caucasian-vs-AfricanAmerican
3.409800E-01
Caucasian-vs-Asian
3.252400E-01
AfricanAmerican-vs-Asian
2.345000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.320000E-01
Normal-vs-Female
2.752600E-01
Male-vs-Female
8.821200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.892420E-01
Normal-vs-Age(41-60Yrs)
1.241630E-01
Normal-vs-Age(61-80Yrs)
4.340400E-01
Normal-vs-Age(81-100Yrs)
4.265200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.473800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.608800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.002600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.675400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.703600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.042200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.221800E-01
Normal-vs-Daily Drinker
5.406000E-01
Normal-vs-Weekly Drinker
7.567600E-01
Normal-vs-Occasional Drinker
1.994620E-01
Normal-vs-Social Drinker
2.351000E-01
Non Drinker-vs-Daily Drinker
5.419600E-01
Non Drinker-vs-Weekly Drinker
1.345590E-01
Non Drinker-vs-Occasional Drinker
2.728800E-01
Non Drinker-vs-Social Drinker
4.731800E-01
Daily Drinker-vs-Weekly Drinker
4.365800E-01
Daily Drinker-vs-Occasional Drinker
1.019560E-01
Daily Drinker-vs-Social Drinker
2.029400E-01
Weekly Drinker-vs-Occasional Drinker
2.110100E-02
Weekly Drinker-vs-Social Drinker
5.453700E-02
Occasional Drinker-vs-Social Drinker
7.544800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.709000E-01
Normal-vs-Grade 2
6.052000E-02
Normal-vs-Grade 3
4.795600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.789600E-02
Grade 1-vs-Grade 3
9.981600E-02
Grade 1-vs-Grade 4
2.709000E-01
Grade 2-vs-Grade 3
8.686800E-01
Grade 2-vs-Grade 4
6.052000E-02
Grade 3-vs-Grade 4
4.795600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.397000E-01
Normal-vs-NonDiabetic
3.282400E-01
Diabetic-vs-NonDiabetic
4.205800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.636200E-01
Normal-vs-NoPancreatitis
3.424400E-01
Pancreatitis-vs-NoPancreatitis
7.121000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.161000E-01
Normal-vs-N1
2.598200E-01
N0-vs-N1
3.562400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.028800E-01
Normal-vs-TP53-NonMutant
4.699600E-01
TP53-Mutant-vs-TP53-NonMutant
4.575700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
